Nanostics Inc.
PrivateLast Round
Grant
Jun 26, 2025
Total Funding Raised
$4.17M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Nanostics Inc. is a biotechnology company that develops and commercializes non-invasive diagnostic tests using its ClarityDX® platform, which employs machine learning to generate risk scores for various diseases including prostate cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanostics Inc. Comparables
Compare Nanostics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| A3P Biomedical | 85% | |
| LynxDx | 85% | |
| OncoHelix Inc. | 82% |
Nanostics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 26, 2025 | ||||
| VC Round | Apr 23, 2024 | ||||
| Grant | May 1, 2023 | ||||
| Grant | May 28, 2018 |
Key People
Founding team and executive leadership
Nanostics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Genome Alberta | Grant |
| Alberta Cancer Foundation | Grant |
| Alberta Innovates | Grant |
| Genome Canada | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 630% MoM to 11.7K.
- Oct 28, 2025
Expanding offices to Middle, New Jersey for US market entry.
Recent news
Latest coverage and updates
- recognized_asJun 18, 2026
Nanostics Inc recognized as global honoree of the.
Nanostics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nanostics Inc.'s valuation, stock price, and market status.
Is Nanostics Inc. a public or private company?
Nanostics Inc. is a private company.
What is the current stock price of Nanostics Inc.?
Nanostics Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Nanostics Inc. worth (valuation)?
Valuation information for Nanostics Inc. is not publicly available.
Can I buy Nanostics Inc. stock?
Nanostics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Nanostics Inc.'s last funding round?
Nanostics Inc.'s most recent funding round was Grant on June 26, 2025.
Who are the main investors in Nanostics Inc.?
Key investors in Nanostics Inc. include Genome Alberta, Alberta Cancer Foundation, Alberta Innovates, Genome Canada.
Will Nanostics Inc. IPO soon?
No public IPO plans have been announced for Nanostics Inc..
How can I track Nanostics Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nanostics Inc.'s secondary market activity and sign up for updates.